Filing Details

Accession Number:
0001400482-16-000263
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-21 14:16:01
Reporting Period:
2016-11-17
Filing Date:
2016-11-21
Accepted Time:
2016-11-21 14:16:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400482 Acucela Inc. M?????? Pharmaceutical Preparations (2834) 020592619
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651281 Lukas Scheibler C/O Acucela Inc.
1301 Second Ave., Suite 4200
Seattle WA 98101
Evp Of Research & Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-17 2,663 $0.00 2,663 No 4 M Direct
Common Stock Disposition 2016-11-21 2,663 $9.35 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2016-11-17 2,663 $0.00 2,663 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
87,895 No 4 M Direct
Footnotes
  1. The issuer's common stock trades on the Tokyo Stock Exchange under the symbol referenced in the issuer's registration statement on Form S-1 (File No. 333-192900).
  2. Each restricted stock unit (RSU) represents a contingent right to receive (1) share of the issuer's common stock upon settlement. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.
  3. The shares were sold at a price of 1033.8077 Japanese Yen. The U.S. per share price reflects the average of the buy and sell Japanese Yen-to-U.S. Dollar exchange rates on the transaction date divided by the number of shares sold. These shares were sold in multiple transactions at prices ranging from 1030 to 1040 Japanese Yen, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. On August 17, 2015, the reporting person was granted 127,847 RSUs, four year vesting period, with 25% of the RSUs vesting on August 17, 2016, and the remainder vesting thereafter on a monthly pro-rata basis, such that 100% of the RSUs are vested on August 17, 2019, subject to the reporting person's continuing employment through the applicable vesting date.